Results 221 to 230 of about 327,843 (358)
Abstract Efforts to use transcriptomics for toxicity testing have classically relied on the assumption that chemicals consistently produce characteristic transcriptomic signatures that are reflective of their mechanism of action. However, the degree to which transcriptomic responses are conserved across different test methodologies has seldom been ...
Paul Béziers +10 more
wiley +1 more source
Exploring the Novel Pancreatic Lipase-Inhibitory Peptides in <i>Chlorella pyrenoidosa</i>: Preparation, Purification, Identification, and Molecular Docking. [PDF]
Wang D +6 more
europepmc +1 more source
The formation of isopeptide bonds in the SpyTag/SpyCatcher system and its application in the food field ABSTRACT The SpyTag/SpyCatcher system is a modular protein assembly tool based on isopeptide bond‐mediated covalent conjugation, distinguished by mild reaction conditions, rapid ligation rate, and independence from exogenous enzymes or chemical ...
Meng‐meng Cai +6 more
wiley +1 more source
The Effect of Lysolecithin Supplementation on Growth Performance, Nutrient Digestibility, Intestinal Morphology, and Lipid Metabolism in Yellow-Feathered Broilers Fed Diets with Different Fat Levels. [PDF]
Zhang Y, Zhu L, Luo Z, Feng J.
europepmc +1 more source
The Lipase of Pseudomonas fragi III. Enzyme Action in Cream and Butter
S.A. Nashif, F.E. Nelson
openalex +1 more source
Gut‐Targeted Nutraceutical Delivery: Engineering Microbiome‐Responsive Nutraceutical Interfaces
ABSTRACT The gut microbiome plays a central role in maintaining host health, influencing immunity, metabolism, epithelial integrity, and the gut–brain axis. Dysbiosis of this complex microbial ecosystem is implicated in a variety of chronic diseases, including inflammatory bowel disease, metabolic syndrome, and neurological disorders.
Jeyavelkumaran Renukadevi +4 more
wiley +1 more source
Microbial Interactions with Intestinal Lipid Digestion and Absorption: Emerging Targets for Metabolic Disorders. [PDF]
Yin J, Zhang M, Jiang W, Huang X, Yin Y.
europepmc +1 more source
Lipase Activity during Making and Ripening of Cheddar Cheese
Merlin H. Peterson +2 more
openalex +1 more source
PCP‐80% could lessen the pathophysiology of T2DM in terms of controlling blood glucose/lipid levels and enhancing intestinal barrier function, via modulating the intricate web of intestinal microbiota/BAs/BAs signaling pathways. Red vertical arrows denote increases (HPCP‐80% vs. MC), blue vertical arrows indicate decreases (HPCP‐80% vs.
Xiaole Zhao +8 more
wiley +1 more source

